Toll
roads first came to Ireland in 1984 when the Eastlink bridge opened
for business. The Westlink opened six years later.
Both
of Ireland's existing toll routes are operated by the same company,
National Toll Roads (NTR)
It
was the brainchild of Tom Roche, the founder of Roadstone and later
CRH, Irelands largest industrial company.
Tom
Roche, one of the outstanding businessmen of his generation, made
a fortune from Roadstone and CRH. He then proceeded
to lose most of it on the Bula ore deposit.
By
the late 1970's, after a lifetime's work, he was as good as broke.
Such
a setback would have broken a lesser man. Not Tom Roche.
Rather that slink away and lick his wounds, Roche quickly came up
with a new scheme.
He
spotted that, with no bridge to the east of Matt Talbot Bridge,
there was an opportunity to build a toll bridge close to the mouth
of the Liffey.
The
result was the EastLink. It cost approximately £8m to build
in the early 1980's. However Tom Roche stumped up only about
£500,000 of this.
Most
of the rest of the money came from bank loans, mainly from ICC and
AIB.
NTR
followed this up with the WestLink toll bridge in 1990. Its
funding of WestLink was clever.
COMPANY
In
1988 a group of financial institutions invested £8m in NTR in return
for a 52pc shareholding.
This
£8m allowed NTR to put £7.5m of its own money into the WestLink,
with the rest of the £27m cost being provided by bank loans from
the European Investment Bank, Bank of Ireland and AIB.
This
meant that Tom Roche only had to pay £500,000 for his family's NTR
stake, which now stands at about 38pc.
With
NTR shares currently trading around the £6.80 mark, that values
the Roche shareholding at £50m.
In
less than 20 years the value of its investment has grown more than
one hundred-fold.
And
that isn't the half of it. Over the years NTR has been a prodigious
cash cow for its shareholders.
Last
year NTR shareholders were paid £9.3m in dividends. In fact
over the past five years they have received a massive £37.5 million
in cash out of the company.
Approximately
£14.25m of this went to the Roche family.
EastLink
runs until 2015 while
When
combined with the increase in the value of NTR's shares, the
returns achieved by the company's shareholders haven't been good,
more like
off
the scale.
All
of this is good news for NTR shareholders. It's not such good
news for the rest of
|